Immune monitoring and cell sorting

A detailed understanding of cellular immune responses in acute and chronic hepatitis is essential for the development of new drugs against hepatitis B and D infections. This means that standardised immunomonitoring under the necessary security conditions of risk level 3 is required, where immune cells can be sorted and genotypically and phenotypically analysed in molecular detail. For example, this makes it possible for researchers to recognise, whether a virus has been completely removed or remains latent in the cell. These methods facilitate the development of customised (immuno-) therapies for virus elimination.